Leonard S. Schleifer

2013

In 2013, Leonard S. Schleifer earned a total compensation of $36.3M as President and Chief Executive Officer at Regeneron Pharmaceuticals, a 21% increase compared to previous year.

Compensation breakdown

Bonus$2,070,000
Option Awards$33,062,325
Salary$1,035,000
Other$105,340
Total$36,272,665

Schleifer received $33.1M in option awards, accounting for 91.15% of the total pay in 2013.

Schleifer also received $2.1M in bonus, $1M in salary and $105.3K in other compensation.

Rankings

In 2013, Leonard S. Schleifer's compensation ranked 23rd out of 12,159 executive pay records tracked by us. In other words, Schleifer earned more than 99.8% of all executives tracked by us in 2013.

ClassificationRankingPercentile
All
23
out of 12,159
100th
Manufacturing
Division
5
out of 4,562
100th
Chemicals And Allied Products
Major group
2
out of 1,418
100th
Drugs
Industry group
2
out of 1,119
100th
Pharmaceutical Preparations
Industry
2
out of 862
100th
Source: SEC filing on April 26, 2016.

Schleifer's colleagues

We found five more compensation records of executives who worked with Leonard S. Schleifer at Regeneron Pharmaceuticals in 2013.

2013

George Yancopoulos

Regeneron Pharmaceuticals

Chief Scientific Officer

2013

Neil Stahl

Regeneron Pharmaceuticals

Executive Vice President, Research & Development

2013

Robert Landry

Regeneron Pharmaceuticals

Chief Financial Officer

2013

Robert Terifay

Regeneron Pharmaceuticals

Executive Vice President, Commercial

2013

Murray Goldberg

Regeneron Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like